Cover Page	6 Months Ended
Cover Page	Dec. 31, 2025 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2025
Document Transition Report	false
Entity Registrant Name	PROCTER & GAMBLE CO
Entity Incorporation, State or Country Code	OH
Entity File Number	1-434
Entity Tax Identification Number	31-0411980
Entity Address, Address Line One	One Procter & Gamble Plaza
Entity Address, State or Province	Cincinnati
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45202
City Area Code	513
Local Phone Number	983-1100
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	2,324,000,685
Entity Central Index Key	0000080424
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2026
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, without Par Value
Trading Symbol	PG
Security Exchange Name	NYSE
0.110% Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	0.110% Notes due 2026
Trading Symbol	PG26D
Security Exchange Name	NYSE
3.250% EUR Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	3.250% EUR Notes due 2026
Trading Symbol	PG26F
Security Exchange Name	NYSE
4.875% EUR Notes due May 2027
Entity Information [Line Items]
Title of 12(b) Security	4.875% EUR Notes due May 2027
Trading Symbol	PG27A
Security Exchange Name	NYSE
1.200% Notes due 2028
Entity Information [Line Items]
Title of 12(b) Security	1.200% Notes due 2028
Trading Symbol	PG28
Security Exchange Name	NYSE
3.150% EUR Notes due 2028
Entity Information [Line Items]
Title of 12(b) Security	3.150% EUR Notes due 2028
Trading Symbol	PG28B
Security Exchange Name	NYSE
1.250% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.250% Notes due 2029
Trading Symbol	PG29B
Security Exchange Name	NYSE
1.800% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.800% Notes due 2029
Trading Symbol	PG29A
Security Exchange Name	NYSE
6.250% GBP Notes due January 2030
Entity Information [Line Items]
Title of 12(b) Security	6.250% GBP Notes due January 2030
Trading Symbol	PG30
Security Exchange Name	NYSE
0.350% Notes due 2030
Entity Information [Line Items]
Title of 12(b) Security	0.350% Notes due 2030
Trading Symbol	PG30C
Security Exchange Name	NYSE
0.230% Notes due 2031
Entity Information [Line Items]
Title of 12(b) Security	0.230% Notes due 2031
Trading Symbol	PG31A
Security Exchange Name	NYSE
3.250% EUR Notes due 2031
Entity Information [Line Items]
Title of 12(b) Security	3.250% EUR Notes due 2031
Trading Symbol	PG31B
Security Exchange Name	NYSE
5.250% GBP Notes due January 2033
Entity Information [Line Items]
Title of 12(b) Security	5.250% GBP Notes due January 2033
Trading Symbol	PG33
Security Exchange Name	NYSE
2.900% Notes due 2033
Entity Information [Line Items]
Title of 12(b) Security	2.900% Notes due 2033
Trading Symbol	PG33B
Security Exchange Name	NYSE
3.200% EUR Notes due 2034
Entity Information [Line Items]
Title of 12(b) Security	3.200% EUR Notes due 2034
Trading Symbol	PG34C
Security Exchange Name	NYSE
1.875% Notes due 2038
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2038
Trading Symbol	PG38
Security Exchange Name	NYSE
0.900% Notes due 2041
Entity Information [Line Items]
Title of 12(b) Security	0.900% Notes due 2041
Trading Symbol	PG41
Security Exchange Name	NYSE
3.650% Notes due 2045
Entity Information [Line Items]
Title of 12(b) Security	3.650% Notes due 2045
Trading Symbol	PG45
Security Exchange Name	NYSE

Consolidated Statements of Earnings - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2025

Dec. 31, 2024

Income Statement [Abstract]

NET SALES

$ 22,208

$ 21,882

$ 44,594

$ 43,619

Cost of products sold

10,834

10,418

21,721

20,839

Selling, general and administrative expense

6,008

5,723

11,651

11,242

OPERATING INCOME

5,366

5,741

11,222

11,538

Interest expense

(220)

(240)

(417)

(478)

Interest income

115

119

222

254

Other non-operating income/(expense), net

160

224

427

(330)

EARNINGS BEFORE INCOME TAXES

5,421

5,845

11,455

10,985

Income taxes

1,090

1,187

2,343

2,339

NET EARNINGS

4,331

4,659

9,112

8,646

Less: Net earnings attributable to noncontrolling interests

12

29

42

56

NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE

$ 4,319

$ 4,630

$ 9,070

$ 8,589

NET EARNINGS PER COMMON SHARE

Basic (in dollars per share)

^[1]

$ 1.82

$ 1.94

$ 3.82

$ 3.59

Diluted (in dollars per share)

^[1]

$ 1.78

$ 1.88

$ 3.73

$ 3.49

[1]	Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Statement of Comprehensive Income [Abstract]
NET EARNINGS	$ 4,331	$ 4,659	$ 9,112	$ 8,646
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
Foreign currency translation	45	(770)	25	256
Unrealized gains/(losses) on investment securities	2	0	1	1
Unrealized gains/(losses) on defined benefit postretirement plans	(2)	24	1	3
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX	46	(747)	27	260
TOTAL COMPREHENSIVE INCOME	4,377	3,912	9,139	8,906
Less: Comprehensive income attributable to noncontrolling interests	10	26	34	54
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE	$ 4,367	$ 3,887	$ 9,105	$ 8,852

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Jun. 30, 2025
CURRENT ASSETS
Cash and cash equivalents	$ 10,825	$ 9,556
Accounts receivable	6,279	6,185
INVENTORIES
Materials and supplies	2,139	2,022
Work in process	1,007	1,012
Finished goods	4,672	4,516
Total inventories	7,817	7,551
Prepaid expenses and other current assets	1,666	2,100
TOTAL CURRENT ASSETS	26,588	25,392
PROPERTY, PLANT AND EQUIPMENT, NET	24,487	23,897
GOODWILL	41,665	41,650
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET	21,737	21,910
OTHER NONCURRENT ASSETS	12,809	12,381
TOTAL ASSETS	127,286	125,231
CURRENT LIABILITIES
Accounts payable	15,173	15,227
Accrued and other liabilities	10,463	11,318
Debt due within one year	11,062	9,513
TOTAL CURRENT LIABILITIES	36,699	36,058
LONG-TERM DEBT	25,577	24,995
DEFERRED INCOME TAXES	5,974	5,774
OTHER NONCURRENT LIABILITIES	5,719	6,120
TOTAL LIABILITIES	73,969	72,946
SHAREHOLDERS’ EQUITY
Preferred stock	767	777
Common stock	4,009	4,009
Additional paid-in capital	69,010	68,770
Reserve for ESOP debt retirement	(637)	(672)
Accumulated other comprehensive loss	(12,108)	(12,143)
Treasury stock	(141,981)	(138,702)
Retained earnings	133,981	129,973
Noncontrolling interest	276	272
TOTAL SHAREHOLDERS’ EQUITY	53,317	52,284
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 127,286	$ 125,231

Consolidated Balance Sheets (Parenthetical) - shares shares in Millions	Dec. 31, 2025	Jun. 30, 2025
Statement of Financial Position [Abstract]
Common stock, issued (in shares)	4,009.2	4,009.2

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Preferred Stock	Additional Paid-In Capital	Reserve for ESOP Debt Retirement	Accumulated Other Comprehensive Income/(Loss)	Treasury Stock	Retained Earnings	Noncontrolling Interest
Beginning balance (in shares) at Jun. 30, 2024		2,357,051
Beginning balance at Jun. 30, 2024	$ 50,559	$ 4,009	$ 798	$ 67,684	$ (737)	$ (11,900)	$ (133,379)	$ 123,811	$ 272
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	8,646							8,589	56
Other comprehensive income/(loss)	260					263			(3)
Dividends and dividend equivalents:
Common	(4,754)							(4,754)
Preferred	(144)							(144)
Treasury stock purchases (in shares)		(26,269)
Treasury stock purchases	(4,462)						(4,462)
Employee stock plans (in shares)		12,827
Employee stock plans	1,318			598			720
Preferred stock conversions (in shares)		1,243
Preferred stock conversions	0		(10)	1			9
ESOP debt impacts	71				30			41
Noncontrolling interest, net	(51)								(51)
Ending balance (in shares) at Dec. 31, 2024		2,344,852
Ending balance at Dec. 31, 2024	51,443	$ 4,009	788	68,283	(707)	(11,637)	(137,112)	127,544	275
Beginning balance (in shares) at Sep. 30, 2024		2,355,042
Beginning balance at Sep. 30, 2024	52,141	$ 4,009	791	68,102	(707)	(10,893)	(134,823)	125,361	300
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	4,659							4,630	29
Other comprehensive income/(loss)	(747)					(744)			(3)
Dividends and dividend equivalents:
Common	(2,375)							(2,375)
Preferred	(72)							(72)
Treasury stock purchases (in shares)		(14,716)
Treasury stock purchases	(2,520)						(2,520)
Employee stock plans (in shares)		4,057
Employee stock plans	408			181			228
Preferred stock conversions (in shares)		469
Preferred stock conversions	0		(3)				3
Noncontrolling interest, net	(51)								(51)
Ending balance (in shares) at Dec. 31, 2024		2,344,852
Ending balance at Dec. 31, 2024	51,443	$ 4,009	788	68,283	(707)	(11,637)	(137,112)	127,544	275
Beginning balance (in shares) at Jun. 30, 2025		2,341,994
Beginning balance at Jun. 30, 2025	52,284	$ 4,009	777	68,770	(672)	(12,143)	(138,702)	129,973	272
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	9,112							9,070	42
Other comprehensive income/(loss)	27					35			(8)
Dividends and dividend equivalents:
Common	(4,960)							(4,960)
Preferred	(146)							(146)
Treasury stock purchases (in shares)		(23,591)
Treasury stock purchases	(3,529)						(3,529)
Employee stock plans (in shares)		4,304
Employee stock plans	480			238			242
Preferred stock conversions (in shares)		1,294
Preferred stock conversions	0		(10)	1			9
ESOP debt impacts	79				35			44
Noncontrolling interest, net	(30)								(30)
Ending balance (in shares) at Dec. 31, 2025		2,324,001
Ending balance at Dec. 31, 2025	53,317	$ 4,009	767	69,010	(637)	(12,108)	(141,981)	133,981	276
Beginning balance (in shares) at Sep. 30, 2025		2,336,734
Beginning balance at Sep. 30, 2025	53,551	$ 4,009	770	68,917	(637)	(12,156)	(139,845)	132,212	281
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	4,331							4,319	12
Other comprehensive income/(loss)	46					48			(2)
Dividends and dividend equivalents:
Common	(2,478)							(2,478)
Preferred	(73)							(73)
Treasury stock purchases (in shares)		(15,566)
Treasury stock purchases	(2,271)						(2,271)
Employee stock plans (in shares)		2,350
Employee stock plans	224			92			132
Preferred stock conversions (in shares)		483
Preferred stock conversions	0		(3)				3
Noncontrolling interest, net	(14)								(14)
Ending balance (in shares) at Dec. 31, 2025		2,324,001
Ending balance at Dec. 31, 2025	$ 53,317	$ 4,009	$ 767	$ 69,010	$ (637)	$ (12,108)	$ (141,981)	$ 133,981	$ 276

Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Statement of Stockholders' Equity [Abstract]
Dividends and dividend equivalents, common stock (in dollars per share)	$ 1.0568	$ 1.0065	$ 2.1136	$ 2.0130
Dividends and dividend equivalents, preferred stock (in dollars per share)	$ 1.0568	$ 1.0065	$ 2.1136	$ 2.0130

Consolidated Statements of Cash Flows - USD ($)
$ in Millions

6 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Statement of Cash Flows [Abstract]

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD

$ 9,556

$ 9,482

OPERATING ACTIVITIES (1)

Net earnings

9,112

8,646

Depreciation and amortization

1,563

1,434

Share-based compensation expense

262

241

Deferred income taxes

196

221

(Gain)/loss on sale of assets

1

787

Change in accounts receivable

(92)

(262)

Change in inventories

(255)

(170)

Change in accounts payable

239

(286)

Other

(645)

(1,484)

TOTAL OPERATING ACTIVITIES

^[1]

10,380

9,127

INVESTING ACTIVITIES

Capital expenditures

(2,367)

(1,918)

Proceeds from asset sales

16

47

Acquisitions, net of cash acquired

(5)

(6)

Other investing activity

(408)

(153)

TOTAL INVESTING ACTIVITIES

(2,763)

(2,029)

FINANCING ACTIVITIES

Dividends to shareholders

(5,093)

(4,886)

Additions to short-term debt with original maturities of more than three months

4,180

5,905

Reductions in short-term debt with original maturities of more than three months

(3,270)

(571)

Net additions/(reductions) to other short-term debt

(471)

(2,705)

Additions to long-term debt

2,652

995

Reductions in long-term debt

(1,005)

(1,478)

Treasury stock purchases

(3,528)

(4,449)

Impact of stock options and other

208

985

TOTAL FINANCING ACTIVITIES

(6,327)

(6,205)

EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH

(21)

(144)

CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

1,269

748

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

$ 10,825

$ 10,230

[1]	Certain prior period amounts within Operating Activities have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the previously reported Total Operating Activities.

Basis of Presentation	6 Months Ended
Basis of Presentation	Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries ("the Company," "Procter & Gamble," "P&G," "we" or "our") should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.

New Accounting Pronouncements and Policies	6 Months Ended
New Accounting Pronouncements and Policies	Dec. 31, 2025
Accounting Policies [Abstract]
New Accounting Pronouncements and Policies	New Accounting Pronouncements and Policies In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures”. This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. This guidance will require additional disclosures in the Income Tax footnote but will not have a material impact on our Consolidated Financial Statements. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures. In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software”. This guidance amends the accounting for and disclosure of software costs. This amendment is effective for our fiscal year ending June 30, 2029 and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements. In December 2025, the FASB issued ASU No. 2025-10, “Accounting for Government Grants Received by Business Entities”. This amendment provides guidance on the recognition, measurement, and presentation of government grants. This amendment is effective for our fiscal year ending June 30, 2030 and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.

- Definition

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476173/280-10-65-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (i)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 250
-Publisher FASB
-URI https://asc.fasb.org/250/tableOfContent

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

+ Details

Segment Information

6 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Segment Information

Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:

•Beauty: Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants, Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments);

•Grooming: Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming);

•Health Care: Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);

•Fabric & Home Care: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and

•Baby, Feminine & Family Care: Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper).

Operating segments as a percentage of consolidated net sales are as follows:


	% of Net sales by operating segment (1)
	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
Fabric Care	23	%	23	%	23	%	23	%
Home Care	12	%	12	%	12	%	12	%
Baby Care	9	%	9	%	9	%	9	%
Hair Care	9	%	9	%	9	%	9	%
Oral Care	9	%	9	%	8	%	8	%
Family Care	8	%	9	%	8	%	9	%
Grooming	8	%	8	%	8	%	8	%
Personal Health Care	7	%	6	%	7	%	7	%
Feminine Care	6	%	6	%	6	%	6	%
Personal Care	5	%	5	%	6	%	6	%
Skin Care	4	%	4	%	4	%	3	%
Total	100	%	100	%	100	%	100	%

(1)% of Net sales by operating segment excludes sales recorded in Corporate.

The following is a summary of reportable segment results:


	Three Months Ended December 31, 2025
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Corporate		Total Company
Net sales	$	4,039	$	1,794	$	3,406	$	7,686	$	5,123	$	160	$	22,208
Cost of products sold	(1,557)		(732)		(1,373)		(4,064)		(2,762)		(346)		(10,834)
Selling, general and administrative expense	(1,490)		(531)		(1,020)		(1,661)		(1,023)		(284)		(6,008)
Other segment items (1)	—		—		(3)		—		—		58		55
Earnings/(loss) before income taxes	992		531		1,009		1,961		1,338		(412)		5,421
Net earnings/(loss)	$	763	$	417	$	770	$	1,521	$	1,020	$	(161)	$	4,331

Other segment information
Depreciation and amortization	$	103	$	78	$	108	$	186	$	207	$	121	$	803
Capital expenditures	$	86	$	128	$	139	$	318	$	361	$	135	$	1,167

(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).


	Three Months Ended December 31, 2024
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Corporate		Total Company
Net sales	$	3,848	$	1,752	$	3,249	$	7,575	$	5,298	$	159	$	21,882
Cost of products sold	(1,462)		(681)		(1,284)		(3,936)		(2,820)		(235)		(10,418)
Selling, general and administrative expense	(1,390)		(504)		(991)		(1,649)		(1,014)		(175)		(5,723)
Other segment items (1)	—		—		—		(1)		—		104		104
Earnings/(loss) before income taxes	996		568		974		1,989		1,464		(146)		5,845
Net earnings/(loss)	$	780	$	459	$	758	$	1,567	$	1,119	$	(24)	$	4,659

Other segment information
Depreciation and amortization	$	101	$	77	$	101	$	180	$	202	$	46	$	706
Capital expenditures	$	69	$	86	$	135	$	267	$	261	$	107	$	925

(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).


	Six Months Ended December 31, 2025
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Corporate		Total Company
Net sales	$	8,182	$	3,611	$	6,626	$	15,479	$	10,294	$	402	$	44,594
Cost of products sold	(3,181)		(1,475)		(2,716)		(8,208)		(5,532)		(607)		(21,721)
Selling, general and administrative expense	(2,877)		(1,020)		(1,965)		(3,268)		(1,978)		(544)		(11,651)
Other segment items (1)	—		—		3		—		—		230		233
Earnings/(loss) before income taxes	2,124		1,117		1,947		4,003		2,784		(520)		11,455
Net earnings/(loss)	$	1,643	$	881	$	1,489	$	3,100	$	2,125	$	(125)	$	9,112

Other segment information
Depreciation and amortization	$	205	$	158	$	213	$	371	$	413	$	204	$	1,563
Capital expenditures	$	160	$	260	$	248	$	600	$	635	$	463	$	2,367

(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).


	Six Months Ended December 31, 2024
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Corporate		Total Company
Net sales	$	7,741	$	3,475	$	6,397	$	15,285	$	10,400	$	322	$	43,619
Cost of products sold	(2,956)		(1,387)		(2,543)		(7,941)		(5,550)		(463)		(20,839)
Selling, general and administrative expense	(2,722)		(999)		(1,926)		(3,277)		(2,003)		(315)		(11,242)
Other segment items (1)	(1)		—		—		—		—		(553)		(554)
Earnings/(loss) before income taxes	2,063		1,090		1,928		4,066		2,847		(1,009)		10,985
Net earnings/(loss)	$	1,620	$	885	$	1,499	$	3,188	$	2,185	$	(731)	$	8,646

Other segment information
Depreciation and amortization	$	200	$	160	$	198	$	358	$	406	$	112	$	1,434
Capital expenditures	$	118	$	181	$	218	$	471	$	459	$	472	$	1,918

(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating losses comprised primarily of a non-cash charge of $752 for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.

The Chief Operating Decision Maker (CODM) does not use assets by segment to evaluate performance or allocate resources. Therefore, we do not disclose assets by segment.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Goodwill and Intangible Assets

6 Months Ended

Dec. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill is allocated by reportable segment as follows:


	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Total Company
GOODWILL AT JUNE 30, 2025	$	14,229	$	12,993	$	7,941	$	1,848	$	4,640	$	41,650
Acquisitions and divestitures	—		—		—		—		—		—
Translation and other	5		7		(2)		2		3		15
GOODWILL AT DECEMBER 31, 2025	$	14,234	$	12,999	$	7,939	$	1,850	$	4,643	$	41,665

Goodwill increased from June 30, 2025, primarily due to currency translation.

Identifiable intangible assets at December 31, 2025, were comprised of:


	Gross Carrying Amount		Accumulated Amortization
Intangible assets with determinable lives	$	9,183	$	(7,157)
Intangible assets with indefinite lives	19,710		—
Total identifiable intangible assets	$	28,893	$	(7,157)

Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended December 31, 2025 and 2024, was $77 and $80, respectively. For the six months ended December 31, 2025 and 2024, amortization expense was $156 and $163, respectively.

Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and indefinite-lived intangible assets have fair values that significantly exceed their underlying carrying values.

Based on our impairment testing performed during the three months ended December 31, 2025, the Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. As of December 31, 2025, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion. Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation, or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger an impairment charge.

The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived intangible asset are the net sales growth rates (including residual growth rate), discount rate and royalty rate.

Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries' currencies relative to the U.S. dollar. The residual growth rate represents the expected rate at which the Gillette brand is expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the brand operating plans and approximates expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment.

The discount rate is based on a weighted average cost of capital that is likely to be expected by a market participant, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.

The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins.

We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing during the three months ended December 31, 2025, utilizing reasonably possible changes in the assumptions for the discount rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.


	Approximate Percent Change in Estimated Fair Value
	+25 bps Discount Rate		-25 bps Growth Rates		-50 bps Royalty Rate
Gillette indefinite-lived intangible asset	(5)	%	(5)	%	(4)	%

Earnings Per Share

6 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

Earnings Per Share

Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other share-based awards based on the treasury stock method and the assumed conversion of preferred stock.

Net earnings per common share were calculated as follows:


CONSOLIDATED AMOUNTS	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
Net earnings attributable to P&G (Diluted)	$	4,319	$	4,630	$	9,070	$	8,589
Less: Preferred dividends	73		72		146		144
Net earnings attributable to P&G available to common shareholders (Basic)	$	4,247	$	4,558	$	8,924	$	8,445

SHARES IN MILLIONS
Basic weighted average common shares outstanding	2,335.3		2,351.9		2,338.7		2,354.1
Add effect of dilutive securities:
Stock options and other unvested equity awards (1)	20.0		34.9		22.7		36.4
Convertible preferred shares (2)	68.7		71.3		69.0		71.6
Diluted weighted average common shares outstanding	2,424.0		2,458.1		2,430.4		2,462.1

NET EARNINGS PER COMMON SHARE
Basic	$	1.82	$	1.94	$	3.82	$	3.59
Diluted	$	1.78	$	1.88	$	3.73	$	3.49

(1)For the three months ended December 31, 2025 and 2024, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 23 million and 8 million, respectively. For the six months ended December 31, 2025 and 2024, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 19 million and 4 million, respectively.

(2)An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

Share-Based Compensation and Postretirement Benefits

6 Months Ended

Dec. 31, 2025

Retirement Benefits [Abstract]

Share-Based Compensation and Postretirement Benefits

The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:


	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
Share-based compensation expense	$	140	$	136	$	262	$	241
Net periodic benefit cost for pension benefits	26		26		65		63
Net periodic benefit (credit) for other retiree benefits	(149)		(180)		(302)		(360)

Risk Management Activities and Fair Value Measurements

6 Months Ended

Dec. 31, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Risk Management Activities and Fair Value Measurements

As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the six months ended December 31, 2025.

The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented.

Cash equivalents were $9.4 billion and $8.3 billion as of December 31, 2025 and June 30, 2025, respectively, and are classified as Level 1 within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods presented.

The fair value of long-term debt was $31.3 billion and $29.5 billion as of December 31, 2025 and June 30, 2025, respectively. This includes the current portion of long-term debt instruments ($6.4 billion and $5.3 billion as of December 31, 2025 and June 30, 2025, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.

Disclosures about Financial Instruments

The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2025 and June 30, 2025, are as follows:


	Notional Amount				Fair Value Asset				Fair Value (Liability)
	December 31, 2025		June 30, 2025		December 31, 2025		June 30, 2025		December 31, 2025		June 30, 2025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts	$	5,336	$	3,280	$	—	$	—	$	(207)	$	(201)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts	$	11,992	$	11,874	$	3	$	—	$	(502)	$	(860)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS	$	17,328	$	15,154	$	3	$	—	$	(709)	$	(1,061)

DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts	$	4,381	$	3,576	$	30	$	19	$	(4)	$	—

TOTAL DERIVATIVES AT FAIR VALUE	$	21,709	$	18,730	$	33	$	19	$	(712)	$	(1,062)

The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $5.1 billion and $3.1 billion as of December 31, 2025 and June 30, 2025, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $12.4 billion and $11.2 billion as of December 31, 2025 and June 30, 2025, respectively. The increase in the notional balance of interest rate contracts designated as fair value hedges is driven by debt portfolio rebalancing to meet interest rate risk management objectives.

Derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. Derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.

Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a liability position was $706 and $1.1 billion as of December 31, 2025 and June 30, 2025, respectively. The Company has not been required to post collateral as a result of these contractual features.

Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:


	Amount of Gain/(Loss) Recognized in OCI on Derivatives
	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts	$	(17)	$	857	$	(3)	$	356

(1) For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $65 and $57 for the three months ended December 31, 2025 and 2024, respectively. The amount of gain excluded from effectiveness testing was $136 and $107 for the six months ended December 31, 2025 and 2024, respectively.

(2) In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain recognized in Accumulated other comprehensive income (AOCI) for such instruments was $9 and $825 for the three months ended December 31, 2025 and 2024, respectively. The amount of gain recognized in AOCI for such instruments was $39 and $215 for the six months ended December 31, 2025 and 2024, respectively.


	Amount of Gain/(Loss) Recognized in Earnings
	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts	$	(12)	$	34	$	(5)	$	110
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts	$	28	$	(174)	$	22	$	(48)

The gains/(losses) on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in Selling, general and administrative expense (SG&A).

Accumulated Other Comprehensive Income/(Loss)

6 Months Ended

Dec. 31, 2025

Equity [Abstract]

Accumulated Other Comprehensive Income/(Loss)

The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component:


	Investment Securities		Postretirement Benefit Plans		Foreign Currency Translation		Total AOCI
BALANCE AT JUNE 30, 2025, NET OF TAX	$	9	$	(777)	$	(11,375)	$	(12,143)
Other comprehensive income/(loss), before tax:
OCI before reclassifications	1		(12)		33		23
Amounts reclassified to the Consolidated Statement of Earnings	—		14		—		14
Total other comprehensive income/(loss), before tax	1		2		33		36
Tax effect	(1)		—		(8)		(9)
Total other comprehensive income/(loss), net of tax	1		1		25		27
Less: OCI attributable to noncontrolling interests, net of tax	—		—		(9)		(8)
BALANCE AT DECEMBER 31, 2025, NET OF TAX	$	10	$	(776)	$	(11,342)	$	(12,108)

Foreign currency translation includes financial statement translation and changes in fair value of net investment hedges (see Note 7).

Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and included in the computation of net periodic postretirement costs.

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in about 70 countries and over 150 taxable jurisdictions and, at any point in time, has 30–40 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2010 and forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit. Based on information currently available, we anticipate over the next 12-month period, audit activity could be completed related to uncertain tax positions in multiple jurisdictions for which we have accrued liabilities of approximately $124, including interest and penalties. Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

Supplier Finance Programs	6 Months Ended
Supplier Finance Programs	Dec. 31, 2025
Payables and Accruals [Abstract]
Supplier Finance Programs	Supplier Finance Programs The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices. The Company also supports a Supply Chain Finance program (“SCF”) with several global financial institutions. Under SCF, the Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers, including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. The amount due to suppliers participating in SCF and included in Accounts payable was approximately $5.8 billion as of December 31, 2025 and June 30, 2025.

Restructuring Program

6 Months Ended

Dec. 31, 2025

Restructuring and Related Activities [Abstract]

Restructuring Program

The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. Consistent with our historical policies for restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for management and segment reporting.

In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. The Company expects to incur approximately $1.5 to $2.0 billion in before-tax restructuring costs over two years. The Company expects to incur half of the costs under this plan by the end of fiscal 2026, with the remainder incurred in fiscal 2027.

The restructuring activities will be executed across the Sector Business Units as well as the Enterprise Markets, Corporate Functions and Global Business Services. These restructuring activities include a plan for a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027. In addition, the plan includes brand and market exits as well as the optimization of the supply chain and other manufacturing processes.

Costs incurred under the plan will consist primarily of costs to separate employees and asset-related costs to exit facilities. The Company will also incur other types of costs outlined below as a direct result of the plan. For the three months ended December 31, 2025, the Company incurred total before tax charges of $369 including $180 in Costs of products sold, $171 in SG&A and $18 in Other non-operating income/(expense), net. For the six months ended December 31, 2025, the Company incurred charges of $584 including $280 in Costs of products sold, $277 in SG&A and $27 in Other non-operating income/(expense), net.

The following table presents restructuring activity for the six months ended December 31, 2025:


	Separations		Asset Related Costs		Other		Total
RESERVE JUNE 30, 2025	$	120	$	—	$	69	$	189
Costs incurred for the three months ended September 30, 2025	124		27		65		215
Costs incurred for the three months ended December 31, 2025	198		83		88		369
Costs incurred for the six months ended December 31, 2025	322		109		152		584

Costs paid/settled for the six months ended December 31, 2025	(172)		(109)		(99)		(380)
RESERVE DECEMBER 31, 2025	$	271	$	—	$	122	$	393

Separation Costs

Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on salary levels and past service periods.

Asset-Related Costs

Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing consolidations. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period.

Other Costs

Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include asset removal and termination of contracts related to supply chain redesign.

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2025
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

New Accounting Pronouncements and Policies (Policies)	6 Months Ended
New Accounting Pronouncements and Policies (Policies)	Dec. 31, 2025
Accounting Policies [Abstract]
New Accounting Pronouncements and Policies	New Accounting Pronouncements and Policies In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures”. This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. This guidance will require additional disclosures in the Income Tax footnote but will not have a material impact on our Consolidated Financial Statements. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures. In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software”. This guidance amends the accounting for and disclosure of software costs. This amendment is effective for our fiscal year ending June 30, 2029 and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements. In December 2025, the FASB issued ASU No. 2025-10, “Accounting for Government Grants Received by Business Entities”. This amendment provides guidance on the recognition, measurement, and presentation of government grants. This amendment is effective for our fiscal year ending June 30, 2030 and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.

Segment Information (Tables)

6 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Operating segments as a percentage of consolidated net sales are as follows:


	% of Net sales by operating segment (1)
	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
Fabric Care	23	%	23	%	23	%	23	%
Home Care	12	%	12	%	12	%	12	%
Baby Care	9	%	9	%	9	%	9	%
Hair Care	9	%	9	%	9	%	9	%
Oral Care	9	%	9	%	8	%	8	%
Family Care	8	%	9	%	8	%	9	%
Grooming	8	%	8	%	8	%	8	%
Personal Health Care	7	%	6	%	7	%	7	%
Feminine Care	6	%	6	%	6	%	6	%
Personal Care	5	%	5	%	6	%	6	%
Skin Care	4	%	4	%	4	%	3	%
Total	100	%	100	%	100	%	100	%

(1)% of Net sales by operating segment excludes sales recorded in Corporate.

The following is a summary of reportable segment results:


	Three Months Ended December 31, 2025
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Corporate		Total Company
Net sales	$	4,039	$	1,794	$	3,406	$	7,686	$	5,123	$	160	$	22,208
Cost of products sold	(1,557)		(732)		(1,373)		(4,064)		(2,762)		(346)		(10,834)
Selling, general and administrative expense	(1,490)		(531)		(1,020)		(1,661)		(1,023)		(284)		(6,008)
Other segment items (1)	—		—		(3)		—		—		58		55
Earnings/(loss) before income taxes	992		531		1,009		1,961		1,338		(412)		5,421
Net earnings/(loss)	$	763	$	417	$	770	$	1,521	$	1,020	$	(161)	$	4,331

Other segment information
Depreciation and amortization	$	103	$	78	$	108	$	186	$	207	$	121	$	803
Capital expenditures	$	86	$	128	$	139	$	318	$	361	$	135	$	1,167

(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).


	Three Months Ended December 31, 2024
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Corporate		Total Company
Net sales	$	3,848	$	1,752	$	3,249	$	7,575	$	5,298	$	159	$	21,882
Cost of products sold	(1,462)		(681)		(1,284)		(3,936)		(2,820)		(235)		(10,418)
Selling, general and administrative expense	(1,390)		(504)		(991)		(1,649)		(1,014)		(175)		(5,723)
Other segment items (1)	—		—		—		(1)		—		104		104
Earnings/(loss) before income taxes	996		568		974		1,989		1,464		(146)		5,845
Net earnings/(loss)	$	780	$	459	$	758	$	1,567	$	1,119	$	(24)	$	4,659

Other segment information
Depreciation and amortization	$	101	$	77	$	101	$	180	$	202	$	46	$	706
Capital expenditures	$	69	$	86	$	135	$	267	$	261	$	107	$	925

(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).


	Six Months Ended December 31, 2025
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Corporate		Total Company
Net sales	$	8,182	$	3,611	$	6,626	$	15,479	$	10,294	$	402	$	44,594
Cost of products sold	(3,181)		(1,475)		(2,716)		(8,208)		(5,532)		(607)		(21,721)
Selling, general and administrative expense	(2,877)		(1,020)		(1,965)		(3,268)		(1,978)		(544)		(11,651)
Other segment items (1)	—		—		3		—		—		230		233
Earnings/(loss) before income taxes	2,124		1,117		1,947		4,003		2,784		(520)		11,455
Net earnings/(loss)	$	1,643	$	881	$	1,489	$	3,100	$	2,125	$	(125)	$	9,112

Other segment information
Depreciation and amortization	$	205	$	158	$	213	$	371	$	413	$	204	$	1,563
Capital expenditures	$	160	$	260	$	248	$	600	$	635	$	463	$	2,367

(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).


	Six Months Ended December 31, 2024
	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Corporate		Total Company
Net sales	$	7,741	$	3,475	$	6,397	$	15,285	$	10,400	$	322	$	43,619
Cost of products sold	(2,956)		(1,387)		(2,543)		(7,941)		(5,550)		(463)		(20,839)
Selling, general and administrative expense	(2,722)		(999)		(1,926)		(3,277)		(2,003)		(315)		(11,242)
Other segment items (1)	(1)		—		—		—		—		(553)		(554)
Earnings/(loss) before income taxes	2,063		1,090		1,928		4,066		2,847		(1,009)		10,985
Net earnings/(loss)	$	1,620	$	885	$	1,499	$	3,188	$	2,185	$	(731)	$	8,646

Other segment information
Depreciation and amortization	$	200	$	160	$	198	$	358	$	406	$	112	$	1,434
Capital expenditures	$	118	$	181	$	218	$	471	$	459	$	472	$	1,918

(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating losses comprised primarily of a non-cash charge of $752 for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.

Goodwill and Intangible Assets (Tables)

6 Months Ended

Dec. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

Goodwill is allocated by reportable segment as follows:


	Beauty		Grooming		Health Care		Fabric & Home Care		Baby, Feminine & Family Care		Total Company
GOODWILL AT JUNE 30, 2025	$	14,229	$	12,993	$	7,941	$	1,848	$	4,640	$	41,650
Acquisitions and divestitures	—		—		—		—		—		—
Translation and other	5		7		(2)		2		3		15
GOODWILL AT DECEMBER 31, 2025	$	14,234	$	12,999	$	7,939	$	1,850	$	4,643	$	41,665

Schedule of Finite-Lived Intangible Assets

Identifiable intangible assets at December 31, 2025, were comprised of:


	Gross Carrying Amount		Accumulated Amortization
Intangible assets with determinable lives	$	9,183	$	(7,157)
Intangible assets with indefinite lives	19,710		—
Total identifiable intangible assets	$	28,893	$	(7,157)

Schedule of Indefinite-Lived Intangible Assets

Identifiable intangible assets at December 31, 2025, were comprised of:


	Gross Carrying Amount		Accumulated Amortization
Intangible assets with determinable lives	$	9,183	$	(7,157)
Intangible assets with indefinite lives	19,710		—
Total identifiable intangible assets	$	28,893	$	(7,157)

Schedule of Potential Impacts to Estimated Fair Values

The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.


	Approximate Percent Change in Estimated Fair Value
	+25 bps Discount Rate		-25 bps Growth Rates		-50 bps Royalty Rate
Gillette indefinite-lived intangible asset	(5)	%	(5)	%	(4)	%

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

+ Details

Earnings Per Share (Tables)

6 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

Net earnings per common share were calculated as follows:


CONSOLIDATED AMOUNTS	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
Net earnings attributable to P&G (Diluted)	$	4,319	$	4,630	$	9,070	$	8,589
Less: Preferred dividends	73		72		146		144
Net earnings attributable to P&G available to common shareholders (Basic)	$	4,247	$	4,558	$	8,924	$	8,445

SHARES IN MILLIONS
Basic weighted average common shares outstanding	2,335.3		2,351.9		2,338.7		2,354.1
Add effect of dilutive securities:
Stock options and other unvested equity awards (1)	20.0		34.9		22.7		36.4
Convertible preferred shares (2)	68.7		71.3		69.0		71.6
Diluted weighted average common shares outstanding	2,424.0		2,458.1		2,430.4		2,462.1

NET EARNINGS PER COMMON SHARE
Basic	$	1.82	$	1.94	$	3.82	$	3.59
Diluted	$	1.78	$	1.88	$	3.73	$	3.49

(1)For the three months ended December 31, 2025 and 2024, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 23 million and 8 million, respectively. For the six months ended December 31, 2025 and 2024, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 19 million and 4 million, respectively.

(2)An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

Share-Based Compensation and Postretirement Benefits (Tables)

6 Months Ended

Dec. 31, 2025

Retirement Benefits [Abstract]

Compensation and Employee Benefit Plans

The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:


	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
Share-based compensation expense	$	140	$	136	$	262	$	241
Net periodic benefit cost for pension benefits	26		26		65		63
Net periodic benefit (credit) for other retiree benefits	(149)		(180)		(302)		(360)

Risk Management Activities and Fair Value Measurements (Tables)

6 Months Ended

Dec. 31, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2025 and June 30, 2025, are as follows:


	Notional Amount				Fair Value Asset				Fair Value (Liability)
	December 31, 2025		June 30, 2025		December 31, 2025		June 30, 2025		December 31, 2025		June 30, 2025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts	$	5,336	$	3,280	$	—	$	—	$	(207)	$	(201)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts	$	11,992	$	11,874	$	3	$	—	$	(502)	$	(860)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS	$	17,328	$	15,154	$	3	$	—	$	(709)	$	(1,061)

DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts	$	4,381	$	3,576	$	30	$	19	$	(4)	$	—

TOTAL DERIVATIVES AT FAIR VALUE	$	21,709	$	18,730	$	33	$	19	$	(712)	$	(1,062)

Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)

Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:


	Amount of Gain/(Loss) Recognized in OCI on Derivatives
	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts	$	(17)	$	857	$	(3)	$	356

(1) For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $65 and $57 for the three months ended December 31, 2025 and 2024, respectively. The amount of gain excluded from effectiveness testing was $136 and $107 for the six months ended December 31, 2025 and 2024, respectively.

(2) In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain recognized in Accumulated other comprehensive income (AOCI) for such instruments was $9 and $825 for the three months ended December 31, 2025 and 2024, respectively. The amount of gain recognized in AOCI for such instruments was $39 and $215 for the six months ended December 31, 2025 and 2024, respectively.

Derivative Instruments, Gain (Loss)


	Amount of Gain/(Loss) Recognized in Earnings
	Three Months Ended December 31				Six Months Ended December 31
	2025		2024		2025		2024
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts	$	(12)	$	34	$	(5)	$	110
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts	$	28	$	(174)	$	22	$	(48)

Accumulated Other Comprehensive Income/(Loss) (Tables)

6 Months Ended

Dec. 31, 2025

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component:


	Investment Securities		Postretirement Benefit Plans		Foreign Currency Translation		Total AOCI
BALANCE AT JUNE 30, 2025, NET OF TAX	$	9	$	(777)	$	(11,375)	$	(12,143)
Other comprehensive income/(loss), before tax:
OCI before reclassifications	1		(12)		33		23
Amounts reclassified to the Consolidated Statement of Earnings	—		14		—		14
Total other comprehensive income/(loss), before tax	1		2		33		36
Tax effect	(1)		—		(8)		(9)
Total other comprehensive income/(loss), net of tax	1		1		25		27
Less: OCI attributable to noncontrolling interests, net of tax	—		—		(9)		(8)
BALANCE AT DECEMBER 31, 2025, NET OF TAX	$	10	$	(776)	$	(11,342)	$	(12,108)

Restructuring Program (Tables)

6 Months Ended

Dec. 31, 2025

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve by Type of Cost

The following table presents restructuring activity for the six months ended December 31, 2025:


	Separations		Asset Related Costs		Other		Total
RESERVE JUNE 30, 2025	$	120	$	—	$	69	$	189
Costs incurred for the three months ended September 30, 2025	124		27		65		215
Costs incurred for the three months ended December 31, 2025	198		83		88		369
Costs incurred for the six months ended December 31, 2025	322		109		152		584

Costs paid/settled for the six months ended December 31, 2025	(172)		(109)		(99)		(380)
RESERVE DECEMBER 31, 2025	$	271	$	—	$	122	$	393

Segment Information - Additional Information (Details)	6 Months Ended
Segment Information - Additional Information (Details)	Dec. 31, 2025 segment
Segment Reporting [Abstract]
Number of reportable segments	5

Segment Information - Percent Of Sales By Business Unit (Details) - Revenue Benchmark - Product Concentration Risk - Operating Segments	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Segment Reporting Information [Line Items]
Concentration risk (in percent)	100.00%	100.00%	100.00%	100.00%
Fabric & Home Care \| Fabric Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	23.00%	23.00%	23.00%	23.00%
Fabric & Home Care \| Home Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	12.00%	12.00%	12.00%	12.00%
Baby, Feminine & Family Care \| Baby Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	9.00%	9.00%	9.00%	9.00%
Baby, Feminine & Family Care \| Family Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	8.00%	9.00%	8.00%	9.00%
Baby, Feminine & Family Care \| Feminine Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	6.00%	6.00%	6.00%	6.00%
Beauty \| Hair Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	9.00%	9.00%	9.00%	9.00%
Beauty \| Personal Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	5.00%	5.00%	6.00%	6.00%
Beauty \| Skin Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	4.00%	4.00%	4.00%	3.00%
Grooming \| Grooming
Segment Reporting Information [Line Items]
Concentration risk (in percent)	8.00%	8.00%	8.00%	8.00%
Health Care \| Oral Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	9.00%	9.00%	8.00%	8.00%
Health Care \| Personal Health Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	7.00%	6.00%	7.00%	7.00%

Segment Information - Segment Results (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Segment Reporting Information [Line Items]
Net sales	$ 22,208	$ 21,882	$ 44,594	$ 43,619
Cost of products sold	(10,834)	(10,418)	(21,721)	(20,839)
Selling, general and administrative expense	(6,008)	(5,723)	(11,651)	(11,242)
Other segment items	55	104	233	(554)
EARNINGS BEFORE INCOME TAXES	5,421	5,845	11,455	10,985
Net earnings/(loss)	4,331	4,659	9,112	8,646
Depreciation and amortization	803	706	1,563	1,434
Capital expenditures	1,167	925	2,367	1,918
Foreign currency translation losses non-cash charge				752
Corporate
Segment Reporting Information [Line Items]
Net sales	160	159	402	322
Cost of products sold	(346)	(235)	(607)	(463)
Selling, general and administrative expense	(284)	(175)	(544)	(315)
Other segment items	58	104	230	(553)
EARNINGS BEFORE INCOME TAXES	(412)	(146)	(520)	(1,009)
Net earnings/(loss)	(161)	(24)	(125)	(731)
Depreciation and amortization	121	46	204	112
Capital expenditures	135	107	463	472
Beauty \| Operating Segments
Segment Reporting Information [Line Items]
Net sales	4,039	3,848	8,182	7,741
Cost of products sold	(1,557)	(1,462)	(3,181)	(2,956)
Selling, general and administrative expense	(1,490)	(1,390)	(2,877)	(2,722)
Other segment items	0	0	0	(1)
EARNINGS BEFORE INCOME TAXES	992	996	2,124	2,063
Net earnings/(loss)	763	780	1,643	1,620
Depreciation and amortization	103	101	205	200
Capital expenditures	86	69	160	118
Grooming \| Operating Segments
Segment Reporting Information [Line Items]
Net sales	1,794	1,752	3,611	3,475
Cost of products sold	(732)	(681)	(1,475)	(1,387)
Selling, general and administrative expense	(531)	(504)	(1,020)	(999)
Other segment items	0	0	0	0
EARNINGS BEFORE INCOME TAXES	531	568	1,117	1,090
Net earnings/(loss)	417	459	881	885
Depreciation and amortization	78	77	158	160
Capital expenditures	128	86	260	181
Health Care \| Operating Segments
Segment Reporting Information [Line Items]
Net sales	3,406	3,249	6,626	6,397
Cost of products sold	(1,373)	(1,284)	(2,716)	(2,543)
Selling, general and administrative expense	(1,020)	(991)	(1,965)	(1,926)
Other segment items	(3)	0	3	0
EARNINGS BEFORE INCOME TAXES	1,009	974	1,947	1,928
Net earnings/(loss)	770	758	1,489	1,499
Depreciation and amortization	108	101	213	198
Capital expenditures	139	135	248	218
Fabric & Home Care \| Operating Segments
Segment Reporting Information [Line Items]
Net sales	7,686	7,575	15,479	15,285
Cost of products sold	(4,064)	(3,936)	(8,208)	(7,941)
Selling, general and administrative expense	(1,661)	(1,649)	(3,268)	(3,277)
Other segment items	0	(1)	0	0
EARNINGS BEFORE INCOME TAXES	1,961	1,989	4,003	4,066
Net earnings/(loss)	1,521	1,567	3,100	3,188
Depreciation and amortization	186	180	371	358
Capital expenditures	318	267	600	471
Baby, Feminine & Family Care \| Operating Segments
Segment Reporting Information [Line Items]
Net sales	5,123	5,298	10,294	10,400
Cost of products sold	(2,762)	(2,820)	(5,532)	(5,550)
Selling, general and administrative expense	(1,023)	(1,014)	(1,978)	(2,003)
Other segment items	0	0	0	0
EARNINGS BEFORE INCOME TAXES	1,338	1,464	2,784	2,847
Net earnings/(loss)	1,020	1,119	2,125	2,185
Depreciation and amortization	207	202	413	406
Capital expenditures	$ 361	$ 261	$ 635	$ 459

Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details) $ in Millions	6 Months Ended
	Dec. 31, 2025 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 41,650
Acquisitions and divestitures	0
Translation and other	15
Ending balance	41,665
Beauty
Goodwill [Roll Forward]
Beginning balance	14,229
Acquisitions and divestitures	0
Translation and other	5
Ending balance	14,234
Grooming
Goodwill [Roll Forward]
Beginning balance	12,993
Acquisitions and divestitures	0
Translation and other	7
Ending balance	12,999
Health Care
Goodwill [Roll Forward]
Beginning balance	7,941
Acquisitions and divestitures	0
Translation and other	(2)
Ending balance	7,939
Fabric & Home Care
Goodwill [Roll Forward]
Beginning balance	1,848
Acquisitions and divestitures	0
Translation and other	2
Ending balance	1,850
Baby, Feminine & Family Care
Goodwill [Roll Forward]
Beginning balance	4,640
Acquisitions and divestitures	0
Translation and other	3
Ending balance	$ 4,643

- Definition

Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-41

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 740
-Name Accounting Standards Codification
-Section 55
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478064/805-740-55-13

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 39
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-39

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482598/350-20-45-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

+ Details

Goodwill and Intangible Assets - Intangible Assets (Details) $ in Millions	Dec. 31, 2025 USD ($)
Intangible assets with determinable lives
Gross Carrying Amount	$ 9,183
Accumulated Amortization	(7,157)
Intangible assets with indefinite lives
Gross Carrying Amount	19,710
Gross Carrying Amount	$ 28,893

Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible asset amortization	$ 77	$ 80	$ 156	$ 163
Indefinite-Lived Intangible Assets [Line Items]
Percentage of fair value in excess of carrying value	10.00%		10.00%
Indefinite-lived intangible asset	$ 19,710		$ 19,710
Gillette
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset	$ 12,800		$ 12,800

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-18

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-11

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-24

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-12

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-6

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

+ Details

Goodwill and Intangible Assets - Fair Value Impacts (Details) - Intangible Assets with Indefinite Lives - Gillette	Dec. 31, 2025
+25 bps Discount Rate
Indefinite-Lived Intangible Assets [Line Items]
Change in estimated fair value (in percent)	(0.05)
-25 bps Growth Rates
Indefinite-Lived Intangible Assets [Line Items]
Change in estimated fair value (in percent)	(0.05)
-50 bps Royalty Rate
Indefinite-Lived Intangible Assets [Line Items]
Change in estimated fair value (in percent)	(0.04)

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

+ Details

Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions

3 Months Ended

6 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2025

Dec. 31, 2024

CONSOLIDATED AMOUNTS

NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE

$ 4,319

$ 4,630

$ 9,070

$ 8,589

Less: Preferred dividends

73

72

146

144

Net earnings attributable to P&G available to common shareholders (Basic)

$ 4,247

$ 4,558

$ 8,924

$ 8,445

SHARES IN MILLIONS

Basic weighted average common shares outstanding (in shares)

2,335.3

2,351.9

2,338.7

2,354.1

Add effect of dilutive securities:

Stock options and other unvested equity awards (in shares)

20.0

34.9

22.7

36.4

Convertible preferred shares (in shares)

68.7

71.3

69.0

71.6

Diluted weighted average common shares outstanding (in shares)

2,424.0

2,458.1

2,430.4

2,462.1

NET EARNINGS PER COMMON SHARE

Basic (in dollars per share)

^[1]

$ 1.82

$ 1.94

$ 3.82

$ 3.59

Diluted (in dollars per share)

^[1]

$ 1.78

$ 1.88

$ 3.73

$ 3.49

Stock options

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Antidilutive securities (in shares)

23.0

8.0

19.0

4.0

[1]	Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

Share-Based Compensation and Postretirement Benefits (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Retirement Benefits [Abstract]
Share-based compensation expense	$ 140	$ 136	$ 262	$ 241
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost (credit)	26	26	65	63
Other Retiree Benefits
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost (credit)	$ (149)	$ (180)	$ (302)	$ (360)

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-7

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (m)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

+ Details

Risk Management Activities and Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions	Dec. 31, 2025	Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash equivalents	$ 9,400	$ 8,300
Fair value of long-term debt	31,300	29,500
Current portion of long-term debt instruments	$ 6,400	$ 5,300
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	OTHER NONCURRENT ASSETS, Prepaid expenses and other current assets	OTHER NONCURRENT ASSETS, Prepaid expenses and other current assets
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued and other liabilities, OTHER NONCURRENT LIABILITIES	Accrued and other liabilities, OTHER NONCURRENT LIABILITIES
Collateral already posted, aggregate fair value	$ 706	$ 1,100
Fair Value Hedging \| Underlying, Other
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the underlying debt obligation	5,100	3,100
Net Investment Hedging \| Underlying, Other
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the underlying debt obligation	$ 12,400	$ 11,200

Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) - USD ($) $ in Millions	Dec. 31, 2025	Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	$ 21,709	$ 18,730
Fair Value Asset	33	19
Fair Value (Liability)	(712)	(1,062)
Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	17,328	15,154
Fair Value Asset	3	0
Fair Value (Liability)	(709)	(1,061)
Interest rate contracts \| Fair Value Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	5,336	3,280
Fair Value Asset	0	0
Fair Value (Liability)	(207)	(201)
Foreign currency interest rate contracts \| Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	4,381	3,576
Fair Value Asset	30	19
Fair Value (Liability)	(4)	0
Foreign currency interest rate contracts \| Net Investment Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	11,992	11,874
Fair Value Asset	3	0
Fair Value (Liability)	$ (502)	$ (860)

Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of gain excluded from effectiveness testing, which was recognized in earnings	$ 65	$ 57	$ 136	$ 107
Gain recognized in AOCI	9	825	39	215
Foreign currency interest rate contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain/(Loss) Recognized in OCI on Derivatives	$ (17)	$ 857	$ (3)	$ 356

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.

+ References + Details

Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Interest rate contracts \| Fair Value Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain/(Loss) Recognized in Earnings	$ (12)	$ 34	$ (5)	$ 110
Foreign currency interest rate contracts \| Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain/(Loss) Recognized in Earnings	$ 28	$ (174)	$ 22	$ (48)

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 53,551	$ 52,141	$ 52,284	$ 50,559
Other comprehensive income/(loss), before tax:
OCI before reclassifications			23
Amounts reclassified to the Consolidated Statement of Earnings			14
Total other comprehensive income/(loss), before tax			36
Tax effect			(9)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX	46	(747)	27	260
Less: OCI attributable to noncontrolling interests, net of tax			(8)
Ending balance	53,317	$ 51,443	53,317	$ 51,443
Total AOCI
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(12,143)
Other comprehensive income/(loss), before tax:
Ending balance	(12,108)		(12,108)
Investment Securities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			9
Other comprehensive income/(loss), before tax:
OCI before reclassifications			1
Amounts reclassified to the Consolidated Statement of Earnings			0
Total other comprehensive income/(loss), before tax			1
Tax effect			(1)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX			1
Less: OCI attributable to noncontrolling interests, net of tax			0
Ending balance	10		10
Postretirement Benefit Plans
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(777)
Other comprehensive income/(loss), before tax:
OCI before reclassifications			(12)
Amounts reclassified to the Consolidated Statement of Earnings			14
Total other comprehensive income/(loss), before tax			2
Tax effect			0
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX			1
Less: OCI attributable to noncontrolling interests, net of tax			0
Ending balance	(776)		(776)
Foreign Currency Translation
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(11,375)
Other comprehensive income/(loss), before tax:
OCI before reclassifications			33
Amounts reclassified to the Consolidated Statement of Earnings			0
Total other comprehensive income/(loss), before tax			33
Tax effect			(8)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX			25
Less: OCI attributable to noncontrolling interests, net of tax			(9)
Ending balance	$ (11,342)		$ (11,342)

Commitments and Contingencies (Details) $ in Millions	6 Months Ended
Commitments and Contingencies (Details) $ in Millions	Dec. 31, 2025 USD ($) taxable_jurisdiction audit country
Loss Contingencies [Line Items]
Number of countries with on the ground operations \| country	70
Number of taxable jurisdictions \| taxable_jurisdiction	150
Accrued existing liabilities for uncertain tax positions \| $	$ 124
Minimum
Loss Contingencies [Line Items]
Number of audits underway	30
Maximum
Loss Contingencies [Line Items]
Number of audits underway	40

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Supplier Finance Programs (Details) - USD ($) $ in Billions	Dec. 31, 2025	Jun. 30, 2025
Supplier Finance Program [Line Items]
Amount due to suppliers participating in SCF	$ 5.8	$ 5.8
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]	Accounts payable	Accounts payable
Minimum
Supplier Finance Program [Line Items]
Payment terms for suppliers (in days)	60 days
Maximum
Supplier Finance Program [Line Items]
Payment terms for suppliers (in days)	180 days

Restructuring Program - Narrative (Details) $ in Millions	3 Months Ended		6 Months Ended
Restructuring Program - Narrative (Details) $ in Millions	Dec. 31, 2025 USD ($)	Sep. 30, 2025 USD ($)	Dec. 31, 2025 USD ($) employee
Restructuring Cost and Reserve [Line Items]
Expected costs, term (in years)			2 years
Expected number of personnel, reduction \| employee			7,000
Restructuring charges	$ 369	$ 215	$ 584
Cost of Sales
Restructuring Cost and Reserve [Line Items]
Restructuring charges	180		280
Selling, General and Administrative Expenses
Restructuring Cost and Reserve [Line Items]
Restructuring charges	171		277
Other Non-operating Income/(Expense)
Restructuring Cost and Reserve [Line Items]
Restructuring charges	18		27
Minimum
Restructuring Cost and Reserve [Line Items]
Historical restructuring costs, before tax	250		250
Expected costs	1,500		1,500
Maximum
Restructuring Cost and Reserve [Line Items]
Historical restructuring costs, before tax	500		500
Expected costs	$ 2,000		$ 2,000

Restructuring Program - Restructuring Activity (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Sep. 30, 2025	Dec. 31, 2025
Restructuring Reserve [Roll Forward]
Beginning balance		$ 189	$ 189
Cost incurred	$ 369	215	584
Cost paid/settled			(380)
Ending balance	393		393
Separations
Restructuring Reserve [Roll Forward]
Beginning balance		120	120
Cost incurred	198	124	322
Cost paid/settled			(172)
Ending balance	271		271
Asset Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance		0	0
Cost incurred	83	27	109
Cost paid/settled			(109)
Ending balance	0		0
Other
Restructuring Reserve [Roll Forward]
Beginning balance		69	69
Cost incurred	88	$ 65	152
Cost paid/settled			(99)
Ending balance	$ 122		$ 122

- Definition

Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.

+ References + Details